Ilovebenefits’s Blog

Just another weblog

Wholesale price increases for brand-name prescription drugs on the rise


The New York Times reports that drug makers have raised wholesale prices of brand-name prescription drugs at the fastest rate in years. The following chart was published in the November 15, 2009 edition of The New York Times:


Boniva (150 mg) osteoporosis Roche $2.96 +18.6%
Actos (30mg) diabetes Takeda $6.74 +16.5%
Singulair (10mg) asthma Merck $3.64 +12.5%
Enbrel (50mg) arthritis Amgen $55.46 +12.1%
Plavix (75mg) anticoagulant Bristol-Myers Squibb $4.80 +8.2%
Nexium (40mg) ulcer AstraZeneca $5.16 +7.1%
Lipitor (10mg) cholesterol Pfizer $2.67 +5.0%


*Change over 12 months ending September 30, 2009


Data Sources: Wolters Kluwer; Stephen Schondelmeyer.

Publication: The New York Times. “Drug Makers Raise Prices in Face of Health Care Reform.” November 15, 2009.


November 19, 2009 - Posted by | drugs, healthcare | , , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: